Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ABBV NASDAQ:AVGO NYSE:PG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$231.63-0.5%$212.45$163.81▼$244.81$408.91B0.516.49 million shs960,286 shsAVGOBroadcom$342.66+1.9%$320.03$138.10▼$374.23$1.62T1.225.96 million shs7.91 million shsPGProcter & Gamble$151.24-0.9%$155.30$149.91▼$180.43$353.98B0.367.91 million shs1.86 million shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie+1.36%+0.84%+9.93%+22.38%+20.59%AVGOBroadcom+0.27%+1.97%+0.45%+21.05%+92.15%PGProcter & Gamble+1.42%-0.70%-4.67%-3.02%-8.66%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$231.63-0.5%$212.45$163.81▼$244.81$408.91B0.516.49 million shs960,286 shsAVGOBroadcom$342.66+1.9%$320.03$138.10▼$374.23$1.62T1.225.96 million shs7.91 million shsPGProcter & Gamble$151.24-0.9%$155.30$149.91▼$180.43$353.98B0.367.91 million shs1.86 million shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie+1.36%+0.84%+9.93%+22.38%+20.59%AVGOBroadcom+0.27%+1.97%+0.45%+21.05%+92.15%PGProcter & Gamble+1.42%-0.70%-4.67%-3.02%-8.66%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABBVAbbVie 2.82Moderate Buy$229.14-1.07% DownsideAVGOBroadcom 3.06Buy$357.224.25% UpsidePGProcter & Gamble 2.55Moderate Buy$172.8914.32% UpsideCurrent Analyst Ratings BreakdownLatest AVGO, PG, and ABBV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025PGProcter & GambleUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$176.0010/3/2025ABBVAbbVieUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$251.0010/3/2025ABBVAbbVieBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$220.00 ➝ $251.0010/2/2025ABBVAbbVieHSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$225.0010/1/2025PGProcter & GambleBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$164.00 ➝ $153.0010/1/2025ABBVAbbVieHsbc Global ResSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold10/1/2025ABBVAbbVieHSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold9/30/2025AVGOBroadcomKeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$400.00 ➝ $420.009/27/2025ABBVAbbVieWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)9/27/2025AVGOBroadcomWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (B-)9/27/2025PGProcter & GambleWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)(Data available from 10/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABBVAbbVie$56.33B7.26$15.02 per share15.42$1.90 per share121.91AVGOBroadcom$51.57B31.38$6.12 per share56.02$14.44 per share23.73PGProcter & Gamble$84.28B4.20$8.42 per share17.97$21.97 per share6.88Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABBVAbbVie$4.28B$2.10110.2316.571.356.45%699.66%13.64%10/31/2025 (Estimated)AVGOBroadcom$5.90B$3.9287.4553.711.8631.59%36.60%15.52%12/11/2025 (Estimated)PGProcter & Gamble$15.97B$6.5123.2320.604.1318.95%32.69%13.49%10/24/2025 (Estimated)Latest AVGO, PG, and ABBV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/31/2025Q3 2025ABBVAbbVie$3.26N/AN/AN/A$15.58 billionN/A10/24/2025Q1 2026PGProcter & Gamble$1.91N/AN/AN/A$22.23 billionN/A9/4/2025Q3 2025AVGOBroadcom$1.66$1.69+$0.03$0.85$15.82 billion$15.95 billion7/31/2025Q2 2025ABBVAbbVie$3.24$2.97-$0.27$0.52$14.93 billion$15.42 billion7/29/2025Q4 2025PGProcter & Gamble$1.42$1.48+$0.06$1.48$20.79 billion$20.89 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABBVAbbVie$6.562.83%N/A312.38%53 YearsAVGOBroadcom$2.360.69%N/A60.20%15 YearsPGProcter & Gamble$4.232.80%N/A64.98%70 YearsLatest AVGO, PG, and ABBV DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date9/5/2025ABBVAbbViequarterly$1.643.08%10/15/202510/15/202511/14/20259/3/2025AVGOBroadcomquarterly$0.590.7%9/22/20259/22/20259/30/20257/8/2025PGProcter & Gamblequarterly$1.05682.68%7/18/20257/18/20258/15/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABBVAbbVie44.140.740.61AVGOBroadcom0.861.501.37PGProcter & Gamble0.490.700.49Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABBVAbbVie70.23%AVGOBroadcom76.43%PGProcter & Gamble65.77%Insider OwnershipCompanyInsider OwnershipABBVAbbVie0.08%AVGOBroadcom2.00%PGProcter & Gamble0.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABBVAbbVie55,0001.77 billion1.77 billionOptionableAVGOBroadcom37,0004.72 billion4.63 billionOptionablePGProcter & Gamble109,0002.34 billion2.34 billionOptionableAVGO, PG, and ABBV HeadlinesRecent News About These CompaniesHere's What to Expect From Procter & Gamble's Next Earnings Report4 hours ago | barchart.comPuzo Michael J Sells 2,005 Shares of Procter & Gamble Company (The) $PGOctober 8 at 6:24 AM | marketbeat.comProcter & Gamble Company (The) $PG Stock Holdings Trimmed by Broderick Brian COctober 8 at 6:17 AM | marketbeat.comLouisiana State Employees Retirement System Sells 2,400 Shares of Procter & Gamble Company (The) $PGOctober 8 at 5:39 AM | marketbeat.comSGL Investment Advisors Inc. Grows Stake in Procter & Gamble Company (The) $PGOctober 8 at 5:02 AM | marketbeat.comProcter & Gamble (NYSE:PG) Stock Unloaded Rep. Katherine M. ClarkOctober 7 at 2:09 PM | marketbeat.comP&G to Webcast the Procter & Gamble 2025 Virtual Annual Meeting of Shareholders October 14October 7 at 9:15 AM | businesswire.comShell Asset Management Co. Raises Stake in Procter & Gamble Company (The) $PGOctober 7 at 7:35 AM | marketbeat.comKingswood Wealth Advisors LLC Sells 19,772 Shares of Procter & Gamble Company (The) $PGOctober 7 at 7:13 AM | marketbeat.comProcter & Gamble Company (The) $PG Shares Acquired by KLP Kapitalforvaltning ASOctober 7 at 6:28 AM | marketbeat.comProcter & Gamble Company (The) $PG Shares Sold by Country Club BankOctober 7 at 5:51 AM | marketbeat.comSeamount Financial Group Inc. Increases Stake in Procter & Gamble Company (The) $PGOctober 7 at 5:41 AM | marketbeat.comSteelPeak Wealth LLC Sells 3,938 Shares of Procter & Gamble Company (The) $PGOctober 7 at 5:33 AM | marketbeat.comDrake & Associates LLC Invests $417,000 in Procter & Gamble Company (The) $PGOctober 7 at 5:32 AM | marketbeat.comInsider Selling: Procter & Gamble (NYSE:PG) Insider Sells 490 Shares of StockOctober 7 at 4:34 AM | insidertrades.comRecent Report Shows That Rep. Katherine Clark Sold Up to $100K Worth of Procter & Gamble StockOctober 6 at 10:46 PM | benzinga.comProcter & Gamble Executives Cash In on Major Stock Sales!October 6 at 10:11 PM | tipranks.comProcter & Gamble (PG) Stock Declines While Market Improves: Some Information for InvestorsOctober 6 at 6:51 PM | zacks.comInsider Selling: Procter & Gamble (NYSE:PG) Insider Sells 490 Shares of StockOctober 6 at 3:39 PM | marketbeat.comProcter & Gamble (NYSE:PG) Insider Susan Street Whaley Sells 2,408 SharesOctober 6 at 3:39 PM | marketbeat.comInsider Selling: Procter & Gamble (NYSE:PG) CEO Sells 3,227 Shares of StockOctober 6 at 3:39 PM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesNIO's New Dawn: Why Wall Street's Bullish Turn Signals a ComebackBy Jeffrey Neal Johnson | September 19, 20253 AI Infrastructure Stocks With Upside After the Summer RallyBy Chris Markoch | September 18, 2025Why Broadcom's Q3 Earnings Were a Huge Win for AVGO BullsBy Leo Miller | September 10, 2025The Most Upgraded Stocks in Q3: Good News for the S&P 500By Thomas Hughes | September 17, 2025Is Richtech Robotics the Next Big Name in Automation?By Jeffrey Neal Johnson | September 26, 2025AVGO, PG, and ABBV Company DescriptionsAbbVie NYSE:ABBV$231.62 -1.21 (-0.52%) As of 12:10 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.Broadcom NASDAQ:AVGO$342.66 +6.25 (+1.86%) As of 12:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Broadcom Inc. designs, develops, and supplies various semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide. The company operates in two segments, Semiconductor Solutions and Infrastructure Software. It provides set-top box system-on-chips (SoCs); cable, digital subscriber line, and passive optical networking central office/consumer premise equipment SoCs; wireless local area network access point SoCs; Ethernet switching and routing custom silicon solutions; serializer/deserializer application specific integrated circuits; optical and copper, and physical layer devices; and fiber optic components and RF semiconductor devices. The company also offers RF front end modules and filter; Wi-Fi, Bluetooth, and global positioning system/global navigation satellite system SoCs; custom touch controllers; inductive charging; attached small computer system interface, and redundant array of independent disks controllers and adapters; peripheral component interconnect express; fiber channel host bus adapters; read channel based SoCs; custom flash controllers; preamplifiers; optocouplers, industrial fiber optics, and motion control encoders and subsystems; light emitting diode, ethernet PHYs, switch ICs, and camera microcontrollers. Its products are used in various applications, including enterprise and data center networking, home connectivity, set-top boxes, broadband access, telecommunication equipment, smartphones and base stations, data center servers and storage systems, factory automation, power generation and alternative energy systems, and electronic displays. Broadcom Inc. was founded in 1961 and is headquartered in Palo Alto, California.Procter & Gamble NYSE:PG$151.24 -1.30 (-0.85%) As of 12:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Archer Aviation Stock Is Soaring—And What Comes Next Lithium Americas: Why This 31% Rally Is More Than Just a Headline AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector 3 Dividend Aristocrats to Buy Before Year’s End The Juice Is Loose: Why Plug Power's Rally Is Just the Beginning Joby's Stock Rallies as Public Flights Validate Global Game Plan SharkNinja Is Flashing a Buy Signal the Market Is Ignoring Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
